Fund HoldingsSaturn V Capital Management LP

Total Portfolio Value
$198.16M
Total Bought
$41.58M
Total Sold
$61.77M
Net Transaction
-$20.19M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
CENTESSA PHARMACEUTICALS PLC0448,692+448,69206,4523.26%+6,452
AMYLYX PHARMACEUTICALS INC(AMLX)889,0732,426,436+1,537,3633,3618,5904.33%+5,229
MERUS N V234,637323,211+88,5749,86613,6046.87%+3,737
ASCENDIS PHARMA A/S(ASND)198,977199,264+28727,39331,05715.67%+3,664
OCULAR THERAPEUTIX INC(OCUL)191,456598,191+406,7351,6354,3852.21%+2,750
XENON PHARMACEUTICALS INC(XENE)322,470413,711+91,24112,64113,8807.00%+1,239
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
100,000116,353+16,3532,5702,3821.20%-188
SYNDAX PHARMACEUTICALS INC(SNDX)988,5281,041,280+52,75213,06812,7926.46%-276
MBX BIOSCIENCES INC(MBX)18,0000-18,0003320-332
SILENCE THERAPEUTICS PLC395,024732,463+337,4392,7182,0661.04%-652
CRINETICS PHARMACEUTICALS IN(CRNX)59,12559,017-1083,0231,9791.00%-1,044
ABIVAX SA(ABVX)653,071552,926-100,1454,7803,4561.74%-1,325
KALVISTA PHARMACEUTICALS INC556,489255,060-301,4294,7132,9431.49%-1,770
COGENT BIOSCIENCES INC(COGT)1,498,4251,480,020-18,40511,6888,8654.47%-2,822
CG ONCOLOGY INC(CGON)593,262577,696-15,56617,01514,1487.14%-2,867
CELCUITY INC(CELC)1,063,7831,093,677+29,89413,92511,0575.58%-2,868
INOZYME PHARMA INC1,374,582499,254-875,3283,8084540.23%-3,353
IRONWOOD PHARMACEUTICALS INC814,5330-814,5333,6080-3,608
ARGENX SE(ARGX)19,75413,862-5,89212,1498,2044.14%-3,944
CONTINEUM THERAPEUTICS INC573,022560,979-12,0438,3953,9161.98%-4,479
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)346,111343,849-2,26218,74213,4346.78%-5,308
DISC MEDICINE INC(IRON)509,406518,177+8,77132,29625,72212.98%-6,574
VAXCYTE INC(PCVX)204,285232,295+28,01016,7238,7714.43%-7,951
CARGO THERAPEUTICS INC1,007,6770-1,007,67714,5310-14,531
CYTOKINETICS INC(CYTK)348,3640-348,36416,3870-16,387
Page 1 of 1